Trials / Withdrawn
WithdrawnNCT01265836
Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,064 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment (statin or combination) reaching the LDL-C goals according to the updated 2004 National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines.
Detailed description
MC MD
Conditions
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2010-12-23
- Last updated
- 2011-04-12
Source: ClinicalTrials.gov record NCT01265836. Inclusion in this directory is not an endorsement.